JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banan, A.
Right arrow Articles by Keshavarzian, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banan, A.
Right arrow Articles by Keshavarzian, A.

Vol. 303, Issue 1, 17-28, October 2002

Activation of delta -Isoform of Protein Kinase C Is Required for Oxidant-Induced Disruption of Both the Microtubule Cytoskeleton and Permeability Barrier of Intestinal Epithelia

A. Banan, J. Z. Fields, A. Farhadi, D. A. Talmage, L. Zhang and A. Keshavarzian

Departments of Internal Medicine (Section of Gastroenterology and Nutrition), Pharmacology, and Molecular Physiology, Rush University Medical Center, Chicago, Illinois (A.B., J.Z.F., A.F., L.Z., A.K.); and Institute of Human Nutrition, Columbia University, New York, New York (D.A.T.)

Using monolayers of intestinal (Caco-2) cells, we showed that oxidants disassemble the microtubule cytoskeleton and disrupt barrier integrity (permeability) (Banan et al., 2000a). Because exposure of our parental cells to oxidants causes protein kinase C (PKC)-delta to be translocated to particulate fractions, we hypothesized that PKC-delta activation is required for these oxidant effects. Monolayers of parental Caco-2 cells were incubated with oxidant (H2O2) ± modulators. Other cells were transfected with an inducible plasmid to stably overexpress PKC-delta or with a dominant negative plasmid to stably inhibit the activity of native PKC-delta . In parental cells, oxidants caused translocation of PKC-delta to the particulate (membrane + cytoskeletal) fractions, activation of PKC-delta isoform, increases in monomeric (S1) tubulin and decreases in polymerized (S2) tubulin, disruption of the microtubule cytoarchitecture, and loss of barrier integrity (hyperpermeability). In transfected cells, induction of PKC-delta overexpression by itself (3.5-fold over its basal level) led to oxidant-like disruptive effects. Disruption induced by PKC-delta overexpression was potentiated by oxidants. Overexpressed PKC-delta resided in particulate fractions, indicating its activation. Stable inhibition of native PKC-delta activity (98%) by dominant negative transfection substantially protected against all measures of oxidative disruption. We conclude that 1) oxidants induce loss of intestinal epithelial barrier integrity by disassembling the microtubules in large part through the activation of the PKC-delta isoform; and 2) overexpression and activation of PKC-delta is by itself a sufficient condition for disruption of these cytoskeleton and permeation pathways. Thus, PKC-delta activation may play a key role in intestinal dysfunction in oxidant-induced diseases such as inflammatory bowel disease.


0022-3565/02/3031-0017$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
M. K. Cho, W. D. Kim, S. H. Ki, J.-I. Hwang, S. Choi, C. H. Lee, and S. G. Kim
Role of G{alpha}12 and G{alpha}13 as Novel Switches for the Activity of Nrf2, a Key Antioxidative Transcription Factor
Mol. Cell. Biol., September 1, 2007; 27(17): 6195 - 6208.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Farhadi, A. Keshavarzian, Z. Ranjbaran, J. Z. Fields, and A. Banan
The Role of Protein Kinase C Isoforms in Modulating Injury and Repair of the Intestinal Barrier
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Fleegal, S. Hom, L. K. Borg, and T. P. Davis
Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2012 - H2019.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kaul, V. Anantharam, Y. Yang, C. J. Choi, A. Kanthasamy, and A. G. Kanthasamy
Tyrosine Phosphorylation Regulates the Proteolytic Activation of Protein Kinase C{delta} in Dopaminergic Neuronal Cells
J. Biol. Chem., August 5, 2005; 280(31): 28721 - 28730.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Banan, L. J. Zhang, A. Farhadi, J. Z. Fields, M. Shaikh, C. B. Forsyth, S. Choudhary, and A. Keshavarzian
Critical Role of the Atypical {lambda} Isoform of Protein Kinase C (PKC-{lambda}) in Oxidant-Induced Disruption of the Microtubule Cytoskeleton and Barrier Function of Intestinal Epithelium
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 458 - 471.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Banan, L.J. Zhang, M. Shaikh, J.Z. Fields, A. Farhadi, and A. Keshavarzian
{theta}-Isoform of PKC is required for alterations in cytoskeletal dynamics and barrier permeability in intestinal epithelium: a novel function for PKC-{theta}
Am J Physiol Cell Physiol, July 1, 2004; 287(1): C218 - C234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Banan, L. J. Zhang, A. Farhadi, J. Z. Fields, M. Shaikh, and A. Keshavarzian
PKC-{beta}1 isoform activation is required for EGF-induced NF-{kappa}B inactivation and I{kappa}B{alpha} stabilization and protection of F-actin assembly and barrier function in enterocyte monolayers
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C723 - C738.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. M. Viveiros, M. O'Brien, K. Wigglesworth, and J. J. Eppig
Characterization of Protein Kinase C-{delta} in Mouse Oocytes Throughout Meiotic Maturation and Following Egg Activation
Biol Reprod, November 1, 2003; 69(5): 1494 - 1499.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Banan, J. Z. Fields, L. J. Zhang, M. Shaikh, A. Farhadi, and A. Keshavarzian
{zeta} Isoform of Protein Kinase C Prevents Oxidant-Induced Nuclear Factor-{kappa}B Activation and I-{kappa}B{alpha} Degradation: A Fundamental Mechanism for Epidermal Growth Factor Protection of the Microtubule Cytoskeleton and Intestinal Barrier Integrity
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 53 - 66.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian
Key role of PLC-{gamma} in EGF protection of epithelial barrier against iNOS upregulation and F-actin nitration and disassembly
Am J Physiol Cell Physiol, October 1, 2003; 285(4): C977 - C993.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Banan, A. Farhadi, J. Z. Fields, E. Mutlu, L. Zhang, and A. Keshavarzian
Evidence That Nuclear Factor-{kappa}B Activation Is Critical in Oxidant-Induced Disruption of the Microtubule Cytoskeleton and Barrier Integrity and That Its Inactivation Is Essential in Epidermal Growth Factor-Mediated Protection of the Monolayers of Intestinal Epithelia
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 13 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Banan, A. Farhadi, J. Z. Fields, L. J. Zhang, M. Shaikh, and A. Keshavarzian
The delta -Isoform of Protein Kinase C Causes Inducible Nitric-Oxide Synthase and Nitric Oxide Up-Regulation: Key Mechanism for Oxidant-Induced Carbonylation, Nitration, and Disassembly of the Microtubule Cytoskeleton and Hyperpermeability of Barrier of Intestinal Epithelia
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 482 - 494.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, S. Choudhary, C. B. Forsyth, A. Farhadi, and A. Keshavarzian
{theta} Isoform of Protein Kinase C Alters Barrier Function in Intestinal Epithelium through Modulation of Distinct Claudin Isotypes: A Novel Mechanism for Regulation of Permeability
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 962 - 982.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.